Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Itraconazole for GM-positive bronchial anthracofibrosis
ChiCTR2100048461Phase 4Recruiting
- Sponsor
- People's Hospital of Honghuagang District, Zunyi City
- Start
- Aug 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Bronchial Anthracofibrosis (BAF) comparing Itraconazole with Placebo (2 arms). Primary endpoint: Number of acute attacks. Started Aug 2021; status: recruiting.
02
Drugs
itraconazole
03
Conditions
Bronchial Anthracofibrosis (BAF)
Beyond the preview
Go deeper on ChiCTR2100048461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048461.